Mcdonald Partners LLC Vertex Pharmaceuticals Inc Transaction History

Mcdonald Partners LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 21, 2022	SELL	$273.83 - $305.53 $27,383 - $30,552	-100 Reduced 6.21%	1,510 $437,000
Q1 2022 Apr 29, 2022	BUY	$221.42 - $260.97 $356,486 - $420,161	1,610 New	1,610 $420,000
Q4 2021 Jan 31, 2022	SELL	$177.01 - $223.45 $278,790 - $351,933	-1,575 Closed	0 $0
Q3 2021 Nov 24, 2021	SELL	$181.39 - $202.99 $19,952 - $22,328	-110 Reduced 6.53%	1,575 $286,000
Q3 2021 Oct 28, 2021	BUY	$181.39 - $202.99 $19,952 - $22,328	110 Added 6.98%	1,685 $306,000
Q2 2021 Nov 24, 2021	SELL	$187.49 - $221.1 $20,623 - $24,321	-110 Reduced 6.53%	1,575 $318,000
Q2 2021 Jul 23, 2021	BUY	$187.49 - $221.1 $12,749 - $15,034	68 Added 4.21%	1,685 $340,000
Q1 2021 Nov 24, 2021	SELL	$207.02 - $241.31 $31,053 - $36,196	-150 Reduced 8.49%	1,617 $347,000
Q1 2021 Apr 15, 2021	BUY	$207.02 - $241.31 $19,459 - $22,683	94 Added 5.62%	1,767 $380,000
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $346,327 - $461,898	1,673 New	1,673 $395,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Mcdonald Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Mcdonald Partners LLC with notifications on news.